Press Release TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma Johnson & Johnson · Jul 23
Press Release PHYTOKANA INGREDIENTS COMPLETES $25 MILLION UNIT OFFERING TO ADVANCE VALUE-ADDED AGRI-PROCESSING IN ALBERTA Phytokana Ingredients Inc. · Jul 23
Press Release Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer Caristo Diagnostics · Jul 23
Press Release Beckman Coulter Diagnostics Launches Fully Automated Urinalysis System to Meet Rising Testing Volumes Beckman Coulter Inc · Jul 23
Press Release Portillo’s Appoints Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation Portillo’s Inc. · Jul 23
Press Release Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201 Atsena Therapeutics · Jul 23
Press Release HiBob launches AI Skills Framework and a new AI Skills Assessment Guide to help organizations build workforce readiness for the AI Era HiBob · Jul 23
Press Release PodcastOne (Nasdaq: PODC) Acquires The Magnificent Others with Billy Corgan PodcastOne · Jul 23
Press Release Visiting Media and HotelPORT Announce Strategic Partnership to Redefine Hotel Content Performance Visiting Media · Jul 23
Press Release Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea Incannex Healthcare · Jul 23
Press Release Bitwave Launches Agentic Finance Initiative, Unveils Open-Source Infrastructure for AI-Native Financial Operations Bitwave · Jul 23
Press Release Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH Inhibikase Therapeutics · Jul 23